» Articles » PMID: 31687848

Predictive Factors for Sperm Retrieval from Males with Azoospermia Who Are Eligible for Testicular Sperm Extraction (TESE)

Overview
Publisher Informa Healthcare
Date 2019 Nov 6
PMID 31687848
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to evaluate the predictive value of factors in infertile male patients to retrieve sperm from their testicles before they undergo testicular sperm extraction (TESE). In total, 64 males were enrolled in this study. Infertility was identified as obstructive azoospermia (OA); non-obstructive azoospermia (NOA); Klinefelter syndrome (KS); and cryptozoospermia (Crypt). Age, body mass index and concomitant conditions were noted. Testicular volumes, serum levels of Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), testosterone (T) and prolactin were investigated. Sperm retrieval after TESE was noted as positive or negative. Average age of the cases was 36.8 years. TESE success rate of testicular sperm retrieval rate was 50.0%. Majority of men (83.9%) had a 46, XY karyotype, minority had genetic anomalies, and 5 of were diagnosed with KS - all were TESE-negative. There was no statistical difference in age, testicular volume, presence of varicocele and microcalcifications or hormonal levels in the TESE-positive and negative groups. Smoking as an independent variable was the only risk factor statistically showing (OR = 0.269; p = 0.045) prediction of negative sperm retrieval after the TESE procedure. None of the parameters investigated herein predicted successful TESE outcomes. However, in cases with negative TESE only smoking was identified as a predictive factor for negative sperm retrieval and was established as a risk factor. AZF: azoospermia factor; BMI: body mass index; Crypt: cryptozoospermia; FSH: Follicle-Stimulating Hormone; ICSI: intracytoplasmic sperm injection; IU: international unit; KS: Klinefelter syndrome; LH: Luteinizing Hormone; mL: milliliter; NOA: non-obstructive azoospermia; OA: obstructive azoospermia; T: testosterone; TESA: testicular sperm aspiration; TESE: testicular sperm extraction.

Citing Articles

Diminished DNA binding affinity of DMRT1 caused by heterozygous DM domain mutations is a cause of male infertility.

Maric T, Castillo-Madeen H, Klaric M, Barisic A, Trgovec-Greif L, Murphy M Hum Mol Genet. 2025; 34(6):481-491.

PMID: 39777458 PMC: 11891871. DOI: 10.1093/hmg/ddae197.


Predictors of Successful Testicular Sperm Extraction: A New Era for Men with Non-Obstructive Azoospermia.

Kaltsas A, Stavros S, Kratiras Z, Zikopoulos A, Machairiotis N, Potiris A Biomedicines. 2025; 12(12.

PMID: 39767586 PMC: 11726830. DOI: 10.3390/biomedicines12122679.


AI predictive models and advancements in microdissection testicular sperm extraction for non-obstructive azoospermia: a systematic scoping review.

Jamalirad H, Jajroudi M, Khajehpour B, Sadighi Gilani M, Eslami S, Sabbaghian M Hum Reprod Open. 2025; 2025(1):hoae070.

PMID: 39764557 PMC: 11700607. DOI: 10.1093/hropen/hoae070.


Artificial Intelligence for Clinical Management of Male Infertility, a Scoping Review.

Naik N, Roth B, Lundy S Curr Urol Rep. 2024; 26(1):17.

PMID: 39520645 PMC: 11550229. DOI: 10.1007/s11934-024-01239-z.


Resolving Male Infertility: A Case Report on Treating Obstructive Azoospermia Using SpermMobil in Intracytoplasmic Sperm Injection Procedure.

Tej P, Pareek C, Kalbande A, Bawaskar P, Badge A, Nair N Cureus. 2024; 16(3):e55323.

PMID: 38559533 PMC: 10981844. DOI: 10.7759/cureus.55323.